SPG302 was well tolerated in a trial, with preliminary data supporting the idea the therapy might slow ALS progression.
After my husband, Todd, was diagnosed with ALS, I was shattered and desperate to connect with others who might understand the pain I was feeling.
Target ALS has released a short film about founder Dan Doctoroff’s mission to transform ALS research and bring hope to patients.
The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback